Elevated complement C5a receptor expression on neurons and glia in astrocyte-targeted interleukin-3 transgenic mice

GLIA

Volumn 24, Issue 3, 1998, Pages 338-345

  Paradisis, P Maria ^a   Campbell, Iain L ^b   Barnum, Scott R ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Chemotactic receptor; Cytokines; Hippocampus; Purkinje cells

Indexed keywords

ANTIANEMIC AGENT; BRAIN; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CHEMOTACTIC FACTOR; COMPLEMENT RECEPTOR; CYTOKININ; DISEASE MODEL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATING AGENT; IN SITU HYBRIDIZATION; INFLAMMATION; INTERLEUKIN 3; MACROPHAGE; MESSENGER RNA; MOUSE; NERVE CELL;

ANIMALS; ANTIGENS, CD; ASTROCYTES; CEREBELLUM; CEREBRAL CORTEX; COMPLEMENT C5A; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERLEUKIN-3; MACROPHAGES; MENINGES; MICE; MICE, TRANSGENIC; MICROGLIA; NEUROGLIA; NEURONS; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; RNA, MESSENGER;

EID: 0032210723     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1136(199811)24:3<338::AID-GLIA8>3.0.CO;2-Y     Document Type: Article

References (34)

1. Barker, M.D., Jose, P.J., Williams, T.J., and Burton, D.R. (1986) The chemoattractant des-Arg74-C5a regulates the expression of its own receptor on a monocyte-like cell line. Biochem J., 36:621-624.
2. Burg M., Martin, U., Rheinheimer, C., Köhl, J., Bautsch, W., Böttger, B.C., and Klos, A. (1995) IFN-γ up-regulates the human C5a receptor (CD88) in myeloblastic U937 cells and related cell lines. J. Immunol., 155:4419-4426.
3. Chiang, C.-S., Powell, H.C., Gold, L.H., Samimi, A., and Campbell, I.L. (1996) Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. J. Clin. Invest. 97:1512-1524.
4. Collins, SJ. (1987) The HL-60 promyelocytic leukemia cell line: Proliferation, differentiation, and cellular oncogene expression. Blood, 70:1233-1244.
5. Faustmann, P.M., Krause, D., Dux, R., and Dermietzel, R. (1995) Morphological study in the early stages of complement C5a fragment-induced experimental meningitis: Activation of macrophages and astrocytes. Acta Neuropathol., 89:239-247.
6. Frei, K., Siepl, C., Groscurth, P., Bodmer, S., Schwerdel, C., and Fontana, A. (1987) Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglial cells. Eur. J. Immunol., 17:271-1278.
7. Ganter, S., Northoff, H., Männel, D., and Gebicke-Härter, P.J. (1992) Growth control of cultured microglia. J. Neurosci. Res., 33:218-230.
8. Gasque, P., Chan, P., Fontaine, M., Ischenko, A., Lamacz, M., Götze, O., and Morgan, B.P. (1995) Identification and characterization of the anaphylatoxin receptor on human astrocytes. J. Immunol., 55:4882-4889.
9. Gerard, C. and Gerard, N.P. (1994) C5a anaphylatoxin and its seven transmembrane-segment receptor. Ann. Rev. Immunol., 12:775-808.
10. Kadurugamuwa, J.L., Hengstler, B., Bray, M.A., and Zak, O. (1989) Inhibition of complement-factor-5a-induced inflammatory reactions by prostaglandin E2 in experimental meningitis. J. Infect. Dis., 160:715-719.
11. Kamegai, M., Niijima, K, Kunishita, T., Nishizawa, M., Ogawa, M. Araki, M., Ueki, A., Konishi, Y., and Tabira, T. (1990) Interleukin 3 as a trophic factor for central cholinergic neurons in vitro and in vivo. Neuron, 2:429-436.
12. Konishi, Y., Chui, D.-H., Kunishita, T., Yamamura, T., Higashi, Y., Tabira, T. (1995) Demonstration of the interleukin-3 receptor-associated antigen in the central nervous system. J. Neurosci. Res., 41:572-582.
13. Kriegsmann, J., Keyszer, G.M., Geiler, T., Bräuer, R. Gay, R., and Gay, S. (1995) Expression of vascular cell adhesion molecule-1 mRNA and protein in rheumatoid synovium demonstrated by in situ hybridization and immunohistochemistry. Lab. Invest., 72:209-214.
14. Lacy, M., Jones, J., Whittemore, S.R., Haviland, D.L., Wetsel, R.A., and Barnum, S.R. (1995) Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia. J. Neuroimmunol., 61:71-78.
15. Lawson, L.J., Perry, V.H., Dri, P., and Gordon, S. (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience, 39:151-170.
16. Lee, S.C., Liu, W. Brosnan, C., and Dickson, D.W. (1994) GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures. GLIA, 12:309-318.
17. McKnight, A.J. and Gordon, S. (1996) EGF-TM7: A novel subfamily of seven-transmembrane-region leukocyte cell-surface molecules. Immunol. Today, 17:283-287.
18. Mehler, M.F. and Kessler, J.A. (1997) Hematolymphopoietic and inflammatory cytokines in neural development. Trends Neurosci., 20:57-365.
19. i signaling in mouse microglia. J. Neurosci., 17:615-624.
20. Morgan, B.P. and Gasque, P. (1996) Expression of complement in the brain: role in health and disease. Immunol. Today, 17:461-466.
21. Müller-Ladner, U., Jones, U., Gay, S., Wetsel, R.A., Raine, C., and Barnum, S.R. (1996) Enhanced expression of chemotactic receptors in multiple sclerosis lesions. J. Neurol. Sci., 144:135-144.
22. Murphy, P.M. (1994) The molecular biology of leukocyte chemoattractant receptors. Ann. Rev. Immunol., 12:593-633.
23. Nakajima, K. and Kohsaka, S. (1993) Functional roles of microglia in the brain. Neurosci. Res., 17:137-203.
24. Nolte, C., Moller, T., Walter, T., and Kettenmann, H. (1996) Complement 5a controls motility of murine microglial cells in vitro via activation of an inhibitory G-protein and the rearrangement of the actin cytoskeleton. Neuroscience, 73:1091-1107.
25. Perry, V.H. and Gordon. S. (1988) Macrophages and microglia in the nervous system. Trends Neurosci., 11:273-277.
26. Roth, J., Saremaslani, P., Warhol, M.J., and Heitz, P.U. (1992) Improved accuracy in diagnostic immunohistochemistry, lectin histochemistry, and in situ hybridization using a gold-labeled horseradish peroxidase antibody and silver intensificalion. Lab. Invest., 67:263-269.
27. 3 and cAMP synergistically induce complement 5a receptor messenger RNA. Am. J. Med. Sci., 311:73-79.
28. Rubin, J., Titus, L., and Nanes, M.S. (1991) Regulation of the complement C5a receptor expression in U937 cells by phorbol ester. J. Leuk. Biol., 50:502-508.
29. Spiegel, K., Emmerling, M.R., and Barnum, S.R. (1997) Strategies for inhibition of complement activation in the treatment of neurodegenerative diseases. In: Neurodegeneration: Inflammatory Mechanisms and Management. P.L. Wood., ed. Humana Press, Totowa, NJ, pp. 129-176.
30. Stahel, P.F., Frei, K., Eugster, H.-P., Fontana, A., Hummel, K.M. Wetsel, R.A., Ames, R.S., and Barnum, S.R. (1997a) TNF-α-mediated expression of the receptor for anaphylatoxin C5a on neurons in experimental Listeria meningoencephalitis. J. Immunol, 159:861-869.
31. Stahel, P.F., Kossmann, T., Morganti-Kossmann, M.C., Hans, V.H.J., and Barnum, S.R. (1997b) Experimental diffuse axonal injury induces enhanced neuronal C5a receptor expression in rats. Mol. Brain Res., 205-212.
32. Wetsel, R.A. (1995) Structure, function and cellular expression of complement anaphylatoxin receptors. Curr. Opin. Immuno., 7: 48-53.
33. Williams, C. A., Schupf, N., and Hugh, T.E. (1985) Anaphylatoxin C5a modulation of an alpha-adrenergic receptor system in the rat hypothalamus. J. Neuroimmunol., 9:29-40.
34. Yao, J., Harvath, L., Gilbert, D.L., and Colton, C.A (1990) Chemotaxis by a CNS macrophage, the microglia. J. Neurosci. Res., 27:36-42.